Age, Biography and Wiki

Brent Saunders was born on 6 February, 1970, is an executive. Discover Brent Saunders's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 53 years old?

Popular As N/A
Occupation Chairman and CEO of Bausch + Lomb Founder of Vesper Healthcare Acquisition Chairman of The Beauty Health Company Chairman of Hugel America
Age 54 years old
Zodiac Sign Aquarius
Born 6 February 1970
Birthday 6 February
Birthplace N/A
Nationality

We recommend you to check the complete list of Famous People born on 6 February. He is a member of famous executive with the age 54 years old group.

Brent Saunders Height, Weight & Measurements

At 54 years old, Brent Saunders height not available right now. We will update Brent Saunders's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Brent Saunders Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Brent Saunders worth at the age of 54 years old? Brent Saunders’s income source is mostly from being a successful executive. He is from . We have estimated Brent Saunders's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income executive

Brent Saunders Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2021

In May 2021, Vesper's HydraFacial deal closed, and the new company was renamed The Beauty Health Company, with Saunders taking the role of executive chairman. He also served as interim CEO until February 2022. In June 2022, Saunders was named to the board of medical aesthetics company Hugel America, an arm of South Korea-based Hugel Inc.

2020

In June 2020, Saunders joined the board of BridgeBio Pharma, a company that had an IPO in 2019. In September, Saunders’ special-purpose acquisition company Vesper Healthcare Acquisition publicly launched, raising $400 million. Filings indicated that Saunders owned 20% of the company after the SPAC sale. In December, Saunders made his first deal with Vesper when he acquired HydraFacial, a beauty treatment company, for $1.1 billion.

2019

In May 2019, Saunders survived a proposal brought by hedge fund Appaloosa Management to split Allergan's chairman and CEO roles. In June, pharmaceutical company Abbvie bought Allergan for $63 billion.

2015

In February 2015, Saunders appeared on the cover of Forbes, named as Wall Street's Drug Dealer.

2014

In May 2014, Saunders was named CEO of pharmaceutical company Actavis, after that company acquired Forest Laboratories. In November, Saunders negotiated Actavis' merger with fellow pharmaceutical company Allergan, which closed at $70.5 billion. The new combined company took the Allergan name.

2013

In 2013, as CEO of Bausch + Lomb, he oversaw its acquisition by Valeant Pharmaceuticals (now known as Bausch Health) for $8.7 billion. He joined Valeant in an advisory role to assist with the transition. In October, Saunders joined pharmaceutical company Forest Laboratories as CEO.

2010

In 2010, Saunders was appointed CEO of eye care company Bausch + Lomb.

2009

In 2009, while still president of consumer health care, Saunders was selected to lead the integration team of Schering-Plough's merger with Merck.

2007

In mid-2007, he became president of consumer health care at Schering-Plough, with responsibility for a business unit of products including Coppertone, Dr. Scholl's and Claritin.

2003

In October 2003, Saunders was hired as senior vice president of global compliance and business practices at pharmaceutical company Schering-Plough.

2000

In 2000, Saunders joined PricewaterhouseCoopers as a healthcare compliance manager, and became partner and head of the firm's compliance business advisory services group.

1996

In 1996, while attending law school, Saunders started working part time at Jefferson Health as a compliance officer.

1969

Brent Saunders (1969 or 1970) is an American biopharma executive and entrepreneur. He is known for his merger and acquisition activity, having helped oversee the merger between pharmaceutical companies Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.

Saunders was born in 1969 or 1970 to Charles and Sheila Sounders, an urologist and social worker. He grew up in the South Whitehall area of Pennsylvania, with a twin brother Wayne and sister Reed. He graduated from Parkland High School in 1988. He attended the University of Pittsburgh and served as president of the Student Government Board. He graduated in 1992 with a bachelor's degree in economics and East Asian studies. In 1996, he received an M.B.A. degree and a J.D. degree from Temple University.